Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $18.4600 (2.38%) ($18.4600 - $18.4600) on Wed. Aug. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.09% (three month average) | RSI | 60 | Latest Price | $18.4600(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 7.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWC(58%) IWO(55%) IWM(54%) IBUY(52%) | Factors Impacting EDIT price | EDIT will decline at least -3.045% in a week (0% probabilities). VIXM(-20%) UUP(-15%) TBT(-10%) VXX(-9%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.045% (StdDev 6.09%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $18.81(-1.86%) | 10 Day Moving Average | $17.79(3.77%) | 20 Day Moving Average | $17.02(8.46%) | To recent high | -4.5% | To recent low | 85.8% | Market Cap | $1.146b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |